Hilma Biocare – hilmabiocare
Hilma Biocare is a scientific and research pharmaceutical company site specializing in the development and manufacture of products, intended to improve the quality of life.
HilmaBiocare news
Optimized packaging
Optimized packaging means saving nature. Hilma-Biocare introduces new compact packaging for pre-filled pens. The new packaging requires fewer materials, which is better for the environment. During the transition period, pens will be available in both the old and new packaging. Read
Tirzepatide and Semaglutide are available in a pre-filled pens
Tirzepatide and Semaglutide are available in a pre-filled pens. This solution makes preparation administration as simple as possible and ensures high dosage accuracy. Read
Hilma Bio care Introduces new products – Tirzepatide and Retatrutide.
Hilma-Biocare introduces new products – Tirzepatide and Retatrutide. These innovative medications are designed to treat type 2 diabetes and promote weight loss in obesity. Tirzepatide is a dual-action drug: a GLP-1 and GIP receptor agonist. Retatrutide is a triple agonist of the GLP-1, GIP, and glucagon receptors. These medications suppress appetite and accelerate metabolism,… Read
Product portfolio brand HilmaBiocare
Extensive experience of the HilmaBiocare brand in medicines
Our key focus is generic products.
The team of professional pharmacists is taking care of the quality of the production process to offer high-quality products to customers. We do clinical tests for all of our products before placing them on the market. Hilma Biocare produces only high-quality medicaments that are available at a reasonable
Quality standarts.
HilmaBiocare operates under GMP standards
Products are manufactured in strict accordance with the required chemical composition in sterile conditions, avoiding the insertion of third-party components, and appropriately packaged to guarantee the preservation of all properties throughout the shelf life.
